474 results
Page 5 of 24
8-K
EX-4.2
1ch0 45bdpuy3wb
24 Mar 21
Entry into a Material Definitive Agreement
5:20pm
424B5
1fumjl
24 Mar 21
Prospectus supplement for primary offering
5:14pm
424B5
pep8gd40g 110ulao7i
22 Mar 21
Prospectus supplement for primary offering
4:39pm
S-8
widnf0 34h7
12 Feb 21
Registration of securities for employees
4:23pm
S-8
5qio 6doy0u4
12 Feb 21
Registration of securities for employees
4:21pm
8-K
EX-10.1
qkgjny8ayp
31 Dec 20
Departure of Directors or Certain Officers
4:16pm
DEF 14C
unr1cbnughu
29 Dec 20
Information statement
4:59pm
8-K
EX-10.1
amn6kn6r0v2 p77upgll
23 Jul 20
Departure of Directors or Certain Officers
4:55pm
8-K
EX-4.1
g9n 7q3c50
22 May 20
Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:22pm
8-K
EX-4.2
15g234r c7wjvmlle
22 May 20
Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:22pm
424B4
ondd 59foolbco4n
21 May 20
Prospectus supplement with pricing info
6:04am